CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | Foresite Capital Management VI LLC 10% owner | Purchase | +117,374 | $6.19 | $727K | 2,351,503 |
| 2025-11-18 | Tananbaum James B. Director | Purchase | +117,374 | $6.19 | $727K | 2,351,503 |
| 2025-11-17 | AKKARAJU SRINIVAS Director | Purchase | +914 | $5.51 | $5K | 277,093 |
| 2025-11-17 | Foresite Labs, LLC 10% owner | Purchase | +50,000 | $5.60 | $280K | 2,084,129 |
| 2025-11-17 | Foresite Labs, LLC 10% owner | Purchase | +150,000 | $5.59 | $839K | 2,234,129 |
| 2025-11-17 | Foresite Capital Management VI LLC 10% owner | Purchase | +50,000 | $5.60 | $280K | 2,084,129 |
| 2025-11-17 | Foresite Capital Management VI LLC 10% owner | Purchase | +150,000 | $5.59 | $839K | 2,234,129 |
| 2025-11-17 | Tananbaum James B. Director | Purchase | +50,000 | $5.60 | $280K | 2,084,129 |
| 2025-11-17 | Tananbaum James B. Director | Purchase | +150,000 | $5.59 | $839K | 2,234,129 |
| 2025-11-13 | AKKARAJU SRINIVAS Director | Purchase | +276,179 | $5.25 | $1.4M | 276,179 |
| 2025-07-30 | TETRAULT LYNN A. Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2025-07-30 | Yao Zhengbin Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2025-07-30 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2025-07-30 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2025-07-30 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +49,800 | 49,800 | ||
| 2025-07-29 | Pangali Sanam Chief Legal Officer | Grant or award | +10,000 | 11,111 | ||
| 2025-07-29 | Pangali Sanam Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-07-29 | Richardson Derrick SVP, People and Culture | Grant or award | +42,800 | 42,800 | ||
| 2025-07-29 | Richardson Derrick SVP, People and Culture | Grant or award · Stock Option (Right to Buy) | +64,200 | 64,200 | ||
| 2025-07-29 | Schroer John R. Chief Financial Officer | Grant or award | +28,000 | 28,000 |
Page 5 of 21 · 405 trades